Cargando…
A mitochondrial checkpoint to adaptive anticancer immunity
BCL2 robustly preserves mitochondrial integrity, hence inhibiting innate immune signaling and apoptotic cell death in several cell types. Here, we comment on our recent data demonstrating that BCL2 also limits the ability of dendritic cells to elicit adaptive immune responses, lending support to a u...
Autores principales: | Kepp, Oliver, Liu, Peng, Kroemer, Guido, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583618/ https://www.ncbi.nlm.nih.gov/pubmed/37860277 http://dx.doi.org/10.1080/2162402X.2023.2271693 |
Ejemplares similares
-
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
por: Kepp, Oliver, et al.
Publicado: (2012) -
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014) -
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013) -
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012)